Wed 28 Oct 2026 International edition
Oncology & Cancer Research Unlocking the Genetic Blueprint: How Inherited DNA Steers Tumor Evolution and Cancer Risk
Clinical Trials & Research Strategic Pivot in Oncology: Context Therapeutics Axes CT-95 Program to Preserve Cash and Double Down on Pipeline Assets CTIM-76 and CT-202
Precision Medicine Tiny silica particles wiped out aggressive prostate cancer in mice
Precision Medicine Beyond the Brain: How New Research Links Serotonin Signaling to Progressive Heart Valve Disease
Clinical Immunology Decoding Rheumatoid Arthritis: How a Natural Compound Unlocks a Novel Therapeutic Frontier
Pathology & Histology Revolutionizing Cancer Diagnostics: The Breakthrough of Shock-Scattering Micro-Histotripsy-Aided Fine Needle Aspiration
Medical Biotechnology Decoding the Ghost of the Mountains: Whole-Genome Sequencing Reveals South Africa’s Cape Leopards Are a Distinct Evolutionary Lineage
Healthcare Quality & Safety Global Health on the Brink: Navigating the Aftermath of the 2025 Aid Contraction
Bio-Research & Life Sciences Rewriting the Scientific Paradigm: Monash University Study Proposes Sweeping Overhaul of Human Taxonomy
Healthcare Quality & Safety Raising the Bar: Multi-Center Study Validates Vietnam’s National Outpatient Satisfaction Framework
Hematology & Blood Research Executive Overview: Uncovering Hidden Hematologic Threats Behind Pediatric Gallstones
Clinical Trials & Research AstraZeneca’s Phase III NSCLC Trial Setback: Re-Evaluating the PD-1 Bispecific Strategy in Advanced Oncology

Archive

Tag: offensive